Posted on March 24, 2012 by Gregory B. Williams

Judge Andrews Issues Claim Construction Ruling on Disputed Terms of Patents Covering Drug Used to Treat Pediatric ADHD

  • Print
  • Comments
  • Trackbacks
  • Share Link

By Memorandum Opinion entered by The Honorable Richard G. Andrews in Shire LLC, et al. v. Teva Pharmaceuticals USA Inc., et al., Civil Action No. 10-329-RGA (D.Del., March 22, 2012), the Court issued its claim construction ruling on the disputed terms of three patents, U.S. Patent Numbers 5,854,290, 6,287,599 and 6,811,794, covering the drug Intuniv®, which is used to treat pediatric ADHD.

A complete copy of the Memorandum Opinion is attached.
 

Tags: , , , , , , , , ,
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://delawareintellectualproperty.foxrothschild.com/admin/trackback/274407
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Submission Guidelines Use this form to add a comment to this entry.







Remember personal info?